Isolation of Human Recombinant Therapeutic Monoclonal Anti-Pseudomonas Antibodies

NCT04335383 · clinicaltrials.gov ↗

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Pseudomonas Aeruginosa
Multi-antibiotic Resistance

Interventions

BIOLOGICAL: Isolation of anti-Pseudomonas antibodies from type B lymphocytes

Sponsor

University Hospital, Grenoble